Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study

Table 1 Assessment schedule

Week	BL	Tx	W24	W25	W26	W27	W28	W30	W34	W38	W42	W46	W52
Informed consent	X
Medical history	X	X
Transplantation information		X
Concomitant medication	X	X	X	X	X	X	X	X	X	X	X	X	X
Physical examination	X	X	X	X	X	X	X	X	X	X	X	X	X
Routine lab	X	X	X	X	X	X	X	X	X	X	X	X	X
Urinalysis	X	X	X	X	X	X	X	X	X	X	X	X	X
CMV, EBV and BK viral load			X	X		X		X		X		X	X
MSC infusion				X	X
Renal biopsy		X	X										X
Iohexol clearance			X										X
Immune monitoring		X	X	X^a	X^a	X			X				X
DSA	X	X	X					X					X
Safety assesment	X	X	X	X	X	X	X	X	X	X	X	X	X